Canada · Delayed Price · Currency is CAD Quantum BioPharma Statistics
Total Valuation
CSE:QNTM has a market cap or net worth of CAD 36.47 million. The enterprise value is 29.73 million.
| Market Cap | 36.47M |
| Enterprise Value | 29.73M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:QNTM has 8.09 million shares outstanding. The number of shares has increased by 114.18% in one year.
| Current Share Class | 8.09M |
| Shares Outstanding | 8.09M |
| Shares Change (YoY) | +114.18% |
| Shares Change (QoQ) | +48.15% |
| Owned by Insiders (%) | 5.41% |
| Owned by Institutions (%) | 9.85% |
| Float | 7.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.21 |
| P/TBV Ratio | 7.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.20 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.18 |
| Interest Coverage | -6.81 |
Financial Efficiency
Return on equity (ROE) is -621.46% and return on invested capital (ROIC) is -135.35%.
| Return on Equity (ROE) | -621.46% |
| Return on Assets (ROA) | -51.84% |
| Return on Invested Capital (ROIC) | -135.35% |
| Return on Capital Employed (ROCE) | -202.02% |
| Weighted Average Cost of Capital (WACC) | 11.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.10M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.41% in the last 52 weeks. The beta is 0.43, so CSE:QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -79.41% |
| 50-Day Moving Average | 4.62 |
| 200-Day Moving Average | 6.93 |
| Relative Strength Index (RSI) | 49.56 |
| Average Volume (20 Days) | 10,438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.48M |
| Pretax Income | -35.92M |
| Net Income | -35.73M |
| EBITDA | -16.73M |
| EBIT | -17.48M |
| Earnings Per Share (EPS) | -7.60 |
Balance Sheet
The company has 5.48 million in cash and 1.37 million in debt, with a net cash position of 4.11 million or 0.51 per share.
| Cash & Cash Equivalents | 5.48M |
| Total Debt | 1.37M |
| Net Cash | 4.11M |
| Net Cash Per Share | 0.51 |
| Equity (Book Value) | 8.65M |
| Book Value Per Share | 1.49 |
| Working Capital | 2.36M |
Cash Flow
| Operating Cash Flow | -7.59M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 734,201 |
| Net Borrowing | 1.67M |
| Free Cash Flow | -7.59M |
| FCF Per Share | -0.94 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:QNTM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -114.18% |
| Shareholder Yield | -114.18% |
| Earnings Yield | -97.95% |
| FCF Yield | -20.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 15, 2024. It was a reverse split with a ratio of 0.0153846154.
| Last Split Date | Aug 15, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0153846154 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |